News Search Results
Mar 28, 2025, 10:01 ET Metagenomics Market to Reach $6.71 Billion by 2031, Growing at a CAGR of 15.6% from 2024 -- Exclusive Report by Meticulous Research®
players. The Asia-Pacific region is projected to grow at the highest CAGR, driven by increasing investments in biotechnology, rising healthcare expenditures, and growing collaborations between academic institutions and industry players. Competitive Landscape
More news about: Meticulous Market Research Pvt. Ltd.
Mar 28, 2025, 08:00 ET SkylineDx presents landmark findings from the largest prospective multicenter melanoma GEP trial at SSO 2025
diagnostic service providers globally to bring this test to market and increase patient access. About SkylineDx SkylineDx is a biotechnology company focused on research & development of molecular diagnostics in oncology inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Mar 28, 2025, 07:30 ET Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Mar 28, 2025, 05:45 ET Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors - Contact Levi & Korsinsky
March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 28, 2025, 05:45 ET Shareholders of ICON Public Limited Company Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Mar 27, 2025, 16:05 ET Spyre Therapeutics Announces First Participant Dosed in Phase 1 Trial of SPY003, its Novel Half-life Extended IL-23 Antibody
March 27, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory
More news about: Spyre Therapeutics, Inc.
Mar 27, 2025, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights
March 27, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Mar 27, 2025, 15:38 ET TraceLink Secures Top Honors with BSMA Supply Chain Excellence Award for Multienterprise Information Network Tower (MINT) Innovation
is a global industry organization dedicated to advancing supply chain excellence in the life sciences sector. Bringing together pharmaceutical, biotechnology, medical device, and healthcare industry leaders, BSMA fosters collaboration, innovation, and best practices to enhance supply chain resilience,
More news about: Tracelink, Inc.
Mar 27, 2025, 15:24 ET TraceLink Secures Top Honors with BSMA Supply Chain Excellence Award for Multienterprise Information Network Tower (MINT) Innovation
is a global industry organization dedicated to advancing supply chain excellence in the life sciences sector. Bringing together pharmaceutical, biotechnology, medical device, and healthcare industry leaders, BSMA fosters collaboration, innovation, and best practices to enhance supply chain resilience,
More news about: Tracelink, Inc.
Mar 27, 2025, 12:00 ET Thryv Therapeutics to Participate in the 2025 Piper Sandler Virtual Cardio Day
MONTREAL, March 27, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in the 2025 Piper Sandler Virtual Cardio
More news about: Thryv Therapeutics Inc.
Mar 27, 2025, 12:00 ET ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (3) that the RFPs ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Glancy Prongay & Murray LLP
Mar 27, 2025, 10:45 ET Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR - Verified Market Reports®
Development, Cancer Research), By End-User (Pharmaceutical Companies, Biotechnology Firms), By Technology (Label-Free Technology, Fluorescent Technology), By End-User (Academia and Research Institutes, Pharmaceutical and Biotechnology Companies), By Geographic Scope And Forecast
More news about: Verified Market Reports
Mar 27, 2025, 10:01 ET Precision Fermentation Market is expected to generate a revenue of USD 34.2 Billion by 2031, Globally, at 40.1% CAGR: Verified Market Research®
Precision fermentation is revolutionizing the food and biotechnology industries by enabling the production of high-value ingredients, alternative proteins, and bio-based compounds. Leveraging microbial hosts for targeted
More news about: Verified Market Research
Mar 27, 2025, 09:25 ET Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
website: www.scinai.com About Pincell srl PinCell is a biotechnology company targeting a novel pathological pathway to develop first-in-class anti-inflammatory therapies for the treatment of rare, severe and highly
More news about: Scinai Immunotherapeutics Ltd.
Mar 27, 2025, 09:00 ET LillyDirect platform expands to facilitate access to Alzheimer's disease care
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Mar 27, 2025, 08:05 ET Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation
a registered trademark of Rigel Pharmaceuticals, Inc. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Mar 27, 2025, 08:00 ET BREAKING: Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints
Dermata Therapeutics, Inc. (Nasdaq: DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications, today announced positive topline results from the Company's
More news about: Dermata Therapeutics, Inc.
Mar 27, 2025, 07:33 ET GlycoNex to Present Preclinical Data on GNX1021 at AACR 2025
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced that preclinical data on GNX1021 will be presented
More news about: GlycoNex, Inc.
Mar 27, 2025, 07:00 ET CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
announced the appointment of Alan Glicklich, M.D., to the Company's Board of Directors. Dr. Glicklich has more than 20 years of experience in the biotechnology industry and currently serves as Chief Medical Officer of Nuvig Therapeutics. Previously, he was Chief Medical Officer of Chinook Therapeutics.Other
More news about: CalciMedica, Inc.
Mar 27, 2025, 06:15 ET Epson Signs Bertelkamp Automation as an AutomateFirst Gold Partner
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Mar 27, 2025, 05:45 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA
March 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm
Mar 27, 2025, 05:45 ET The Gross Law Firm Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Mar 27, 2025, 04:00 ET ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference
Spain, March 27, 2025 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 24th
More news about: ARTHEx Biotech
Mar 27, 2025, 03:12 ET Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
Mar 27, 2025, 01:29 ET Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program
ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion